Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort

Abstract

Aims

The aim of this study was to examine whether high-sensitivity C-reactive protein (hs-CRP), N-terminal pro-brain natriuretic peptide (NT-proBNP), and soluble urokinase plasminogen activator receptor (suPAR) carried incremental prognostic value in predicting cardiovascular morbidity and mortality beyond traditional risk factors in apparently healthy individuals.

Methods and results

This was a prospective population-based cohort study comprising 1951 subjects included in the 10-year follow-up of the MONItoring of trends and determinants in CArdiovascular disease (MONICA) study, between 1993 and 1994. The principal endpoint was death from cardiovascular causes. Secondary endpoints were death from any cause, coronary artery disease, heart failure, and cerebrovascular disease. Predictive capabilities of each of the three biomarkers were tested using Cox proportional-hazards regression, Harrell’s concordance index (C-index), and net reclassification improvement (NRI). Study participants were aged 41, 51, 61, or 71 years, and equally distributed between the two sexes. During a median follow-up of 18.5 years (interquartile range: 18.1–19.0), 177 (9.1%) subjects died from a cardiovascular cause. Hs-CRP (adjusted standardized hazard ratio (HR): 1.37, 95% confidence interval (CI): 1.17–1.60), NT-proBNP (HR: 1.90, 95% CI: 1.58–2.29), and suPAR (HR: 1.35, 95% CI: 1.17–1.57) were all significantly associated with cardiovascular deaths after adjustment for age, sex, smoking status, systolic blood pressure, and total cholesterol (p < 0.001 for all). Furthermore, all three biomarkers were significantly associated with significant NRI. However, only NT-proBNP significantly raised the C-index in predicting death from cardiovascular causes when added to the risk factors (C-index 0.860 versus 0.847; p = 0.02).

Conclusions

Hs-CRP, suPAR, and particularly NT-proBNP predicted cardiovascular death and may enhance prognostication beyond traditional risk factors in apparently healthy individuals.

Keywords

Assessment risk biomarkers cardiovascular diseases C-reactive protein natriuretic peptide brain receptor urokinase plasminogen activator

Get full access to this article

View all access options for this article.

References

Wilson

D’Agostino

Levy

, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837–1847.

Conroy

Pyorala

Fitzgerald

, et al. SCORE Project Group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.

Mortensen

Sivesgaard

Jensen

, et al. Traditional SCORE-based health check fails to identify individuals who develop acute myocardial infarction. Dan Med J 2013; 60: A4629–A4629.

Sehestedt

Jeppesen

Hansen

, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 2010; 31: 883–891.

Wang

Arver

Boman

, et al. Testosterone, sex hormone-binding globulin and risk of cardiovascular events: a report from the Outcome Reduction with an Initial Glargine Intervention trial. Eur J Prev Cardiol 2019; 26: 847–854.

Ridker

Rifai

Rose

, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557–1565.

Wang

Larson

Levy

, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655–663.

Wang

Gona

Larson

, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355: 2631–2639.

Olsen

Hansen

Christensen

, et al. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J 2007; 28: 1374–1381.

10.

Zethelius

Berglund

Sundstrom

, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358: 2107–2116.

11.

Diederichsen

Mickley

, et al. Prognostic value of suPAR and hs-CRP on cardiovascular disease. Atherosclerosis 2018; 271: 245–251.

12.

Tunstall-Pedoe

Kuulasmaa

Mahonen

, et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547–1557.

13.

Johnsen

Overvad

Sorensen

, et al. Predictive value of stroke and transient ischemic attack discharge diagnoses in The Danish National Registry of Patients. J Clin Epidemiol 2002; 55: 602–607.

14.

Madsen

Davidsen

Rasmussen

, et al. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003; 56: 124–130.

15.

Schmidt

Sandegaard

, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449–490.

16.

Sundboll

Adelborg

Munch

, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open 2016; 6: e012832–e012832.

17.

Harrell

Jr Califf

Pryor

, et al. Evaluating the yield of medical tests. JAMA 1982; 247: 2543–2546.

18.

Gronnesby

Borgan

. A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal 1996; 2: 315–328.

19.

Pencina

D’Agostino

RBS

Steyerberg

. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30: 11–21.

20.

Olsen

Hansen

Christensen

, et al. New risk markers may change the HeartScore risk classification significantly in one-fifth of the population. J Hum Hypertens 2009; 23: 105–112.

21.

Sehestedt

Lyngbaek

Eugen-Olsen

, et al. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events. Atherosclerosis 2011; 216: 237–243.

22.

Lyngbaek

Marott

Sehestedt

, et al. Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score. Int J Cardiol 2013; 167: 2904–2911.

23.

Welsh

Doolin

Willeit

, et al. N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. Eur Heart J 2013; 34: 443–450.

24.

Dietl

Stark

Zimmermann

, et al. NT-proBNP predicts cardiovascular death in the general population independent of left ventricular mass and function: insights from a large population-based study with long-term follow-up. PLoS One 2016; 11: e0164060–e0164060.

25.

Pareek

Bhatt

Vaduganathan

, et al. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event. Eur J Prev Cardiol 2017; 24: 1648–1659.

26.

Persson

Engstrom

Bjorkbacka

, et al. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmo Diet and Cancer Study. Atherosclerosis 2012; 220: 502–505.

27.

Munkhaugen

Otterstad

Dammen

, et al. The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event. Eur J Prev Cardiol 2018; 25: 923–931.

28.

Pepys

Hirschfield

. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805–1812.

29.

Thuno

Macho

Eugen-Olsen

. suPAR: the molecular crystal ball. Dis Markers 2009; 27: 157–172.

30.

Piepoli

Hoes

Agewall

, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol 2016; 23: NP1–NP96–NP1–NP96.

31.

Ioannidis

Tzoulaki

. Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease. Circ Res 2012; 110: 658–662.

32.

Tzoulaki

Siontis

Evangelou

, et al. Bias in associations of emerging biomarkers with cardiovascular disease. JAMA Intern Med 2013; 173: 664–671.

33.

Song

Parekh-Bhurke

Hooper

, et al. Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies. BMC Med Res Methodol 2009; 9: 79–79.

34.

Siontis

Tzoulaki

Castaldi

, et al. External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. J Clin Epidemiol 2015; 68: 25–34.

35.

Melander

Newton-Cheh

Almgren

, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302: 49–57.

36.

Blankenberg

Salomaa

Makarova

, et al. BiomarCaRE Investigators. Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J 2016; 37: 2428–2437.

37.

Natriuretic Peptides Studies Collaboration. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol 2016; 4: 840–849.

38.

Pletcher

Moran

. Cardiovascular risk assessment. Med Clin North Am 2017; 101: 673–688.

39.

Wang

Larson

Keyes

, et al. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 2007; 115: 1345–1353.

40.

Leening

Vedder

Witteman

, et al. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician’s guide. Ann Intern Med 2014; 160: 122–131.

41.

Kerr

Wang

Janes

, et al. Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology 2014; 25: 114–121.

42.

Diederichsen

Sand

Norgaard

, et al. Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study. Eur J Prev Cardiol 2012; 19: 558–564.

43.

Gerdes

Bronnum-Hansen

Madsen

, et al. Trends in selected biological risk factors for cardiovascular diseases in the Danish MONICA population, 1982-1992. J Clin Epidemiol 2000; 53: 427–434.

44.

Gerdes

Bronnum-Hansen

Osler

, et al. Trends in lifestyle coronary risk factors in the Danish MONICA population 1982–1992. Public Health 2002; 116: 81–88.

45.

Khan

Ning

Shah

, et al. 10-year risk equations for incident heart failure in the general population. J Am Coll Cardiol 2019; 73: 2388–2397.

46.

Olsen

Hansen

Christensen

, et al. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 2005; 46: 660–666.

47.

Olsen

Christensen

Hansen

, et al. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. J Hypertens 2006; 24: 655–661.

48.

Kugler

Hackl

Mueller

, et al. The impact of sample storage time on estimates of association in biomarker discovery studies. J Clin Bioinforma 2011; 1: 9–9.

49.

Ibrahim

Januzzi

Jr . Established and emerging roles of biomarkers in heart failure. Circ Res 2018; 123: 614–629.

50.

Lin

Zhang

. Associations between endothelial nitric oxide synthase gene polymorphisms and the risk of coronary artery disease: a systematic review and meta-analysis of 132 case-control studies. Eur J Prev Cardiol 2019; 26: 160–170.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.35 MB